FDA Adverse Event Injury Summary report: N

REFOBACIN BONE CEMENT R 2X20-3

MDR report key: 24311951 · Received February 11, 2026

Report

Report Number
3006946279-2026-00007
Event Type
Injury
Date Received
February 11, 2026
Date of Event
December 10, 2025
Report Date
April 29, 2026
Manufacturer
BIOMET FRANCE S.A.R.L.
Product Code
MBB
UDI-DI
00887868358371
PMA / PMN Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

(B)(4). D-4: THIS DEVICE IS SOLD OUTSIDE THE US AND THEREFORE NO GUDID INFORMATION EXISTS. THIS DEVICE IS CONSIDERED SIMILAR TO (B)(4). D:10: 159582, OXF ANAT BRG RT LG SIZE 3 PMA, LOT 7500507; 154725, OXF UNI TIB TRAY SZ D RM PMA, LOT J7506082; 166943, OXFORD UNI TWIN-PEG FEMORAL LG, LOT J7670007. G2: FOREIGN - EVENT OCCURRED IN GERMANY. G-4: THE REPORTED PRODUCT IS NOT SOLD IN THE US, THE PRE-MARKET SUBMISSION NUMBER FOR THE SIMILAR PRODUCT SOLD IN THE US IS K171540. THE DEVICE WILL NOT BE RETURNED FOR ANALYSIS; HOWEVER, AN INVESTIGATION OF THE REPORTED EVENT IS IN PROGRESS. ONCE THE INVESTIGATION IS COMPLETED, A SUPPLEMENTAL MEDWATCH 3500A WILL BE SUBMITTED.

Description of Event or Problem · 0

IT WAS REPORTED BY LEGAL THAT A PATIENT WAS REVISED TO A TOTAL KNEE PROSTHESIS APPROXIMATELY ONE YEAR AND NINE MONTHS POST AN INITIAL RIGHT MEDIAL UNICONDYLAR KNEE ARTHROPLASTY. ABOUT A YEAR AND A HALF POST IMPLANTATION, THE PATIENT PRESENTED WITH PAIN WITHOUT A KNOWN TRAUMA OR INJURY. CT SCANS SHOWED FEMORAL COMPONENT IMPLANT FRACTURE WITH FRAGMENT AND BEARING DISPLACEMENT, FEMORAL RADIOLUCENCIES INDICATING LOOSENING, PRONOUNCED SOFT TISSUE CALCIFICATIONS, AND MARKED JOINT EFFUSION. NO FURTHER INFORMATION HAS BEEN PROVIDED AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
379758 REFOBACIN BONE CEMENT R 2X20-3 ORTHOPAEDIC CEMENT, ANTIMICROBIAL MBB BIOMET FRANCE S.A.R.L. W39BAG2405 00887868358371

Patients

Seq Age Sex Outcome Treatment
1 NA Male Required Intervention| H SEE H11 NARRATIVE.